Experience

DualityBio Announces HK$1.64 Billion IPO

April 24, 2025

Cooley advised the underwriters of Duality Biologics (DualityBio), a clinical-stage biotech company focused on the discovery and development of next-generation antibody-drug conjugate therapeutics for patients with cancer and autoimmune diseases, in connection with its HK$1.64 billion global initial public offering (IPO).

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Xander Lee
Partner, Santa Monica
Vince Sampson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Monica Xu
Special Counsel, Shanghai
Hilda Li
Associate, Hong Kong
Zixiang Liu
Associate, Shanghai
Patrick Sharma
Associate, Santa Monica
Yiying Wang
Associate, Shanghai
Yunxiang Xu
Associate, Shanghai
Kaiting Yang
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Tonny Yu
Associate, Hong Kong
Letian Wei
Legal Consultant, Shanghai
Cindy Pan
International Legal Project Manager, Hong Kong
Zoe Wang
International Legal Project Manager, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Jin Wang
Senior Legal Assistant, Beijing

Related Practices & Industries

Earendil Labs Announces Worldwide Exclusive License Agreement With Sanofi

April 17, 2025

Cooley advised Earendil Labs, an artificial intelligence-driven biotech company affiliated with Helixon Therapeutics, in connection with Earendil Labs’ license agreement with Sanofi for two potential first-in-class bispecific antibodies in the field of autoimmune and inflammatory bowel diseases.

Read more

Related contacts

Geoffrey Spolyar
Partner, Boston
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Zack Gong
Associate, Shanghai
Dr. Xiaozhen (Shawn) Yu
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Amanda Pacheco
Associate, Palo Alto
David Burns
Special Counsel, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC

Related Practices & Industries

VISEN Pharmaceuticals Announces HK$783 Million IPO

March 21, 2025

Cooley advised VISEN Pharmaceuticals, a late-stage, near-commercialization biopharmaceutical company focused on providing treatments for select endocrine diseases in Greater China (including Hong Kong, Macau and Taiwan), on its HK$783 million (approximately US$101 million) initial public offering (IPO) on the Stock Exchange of Hong Kong, subject to the exercise of a 15% overallotment option.

Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Will Cai
Partner, Hong Kong
Annie Froehlich
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Aaron Pomeroy
Partner, Colorado
Francis Wheeler
Senior Counsel, Colorado
Hilda Li
Associate, Hong Kong
Ying Liu
Associate, Hong Kong
Amanda Pacheco
Associate, Palo Alto
Hardy Zhou
Associate, New York
Alex Wu
Associate, Shanghai
Philip Kwan
Senior Legal Assistant, Hong Kong
Kaiting Yang
Associate, Hong Kong

Related Practices & Industries

Nuvation Bio Announces up to $250 Million Nondilutive Financings From Sagard Healthcare Partners

February 18, 2025

Cooley advised Nuvation Bio (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, on its nondilutive financings of up to $250 million with Sagard Healthcare Partners.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Addison Pierce
Partner, Chicago
Shimeng Cheng
Special Counsel, San Francisco
Kenneth Guernsey
Senior Counsel , San Francisco
Rodrigo Huerta
Associate, Chicago
Charles A. Watkins II
Associate, Santa Monica
Dr. Jon Cousin
Partner, Washington, DC
Christophe Beauduin
Partner, New York
Sonia Nath
Partner, Washington, DC
Aaron Pomeroy
Partner, Colorado
Eileen Marshall
Partner, Washington, DC
Michael Neumeister
Partner, Los Angeles
Francis Wheeler
Senior Counsel, Colorado
Stacey A. Bradford
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Melissa H. Boyd
Associate, San Francisco
Cara Buchicchio
Associate, New York
Jameson Davis
Associate, Boston
Auguste Humphries
Associate, Washington, DC
Rick Jantz
Associate, Santa Monica
Allison Kutner
Associate, New York
Shelby Saunders
Associate, New York
Dr. Jason Valentine
Associate, Washington, DC
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Yiming Liu
Partner in Charge – Shanghai, Shanghai

Related Practices & Industries

Beihai Biotech Signs Exclusive Licensing, Supply and Commercialization Agreement With Zydus

February 14, 2025

Cooley advised Beihai Biotech, an innovative biopharmaceutical company, on its exclusive licensing, supply and commercialization agreement with Zydus Lifesciences for BEIZRAY.

Read more

Related contacts

Yiming Liu
Partner in Charge – Shanghai, Shanghai
Bin Wang
Special Counsel, Palo Alto
Zack Gong
Associate, Shanghai
James Maton
Co-Partner in Charge – London, London

Related Practices & Industries

View more

Admissions and credentials

New York

Hong Kong (Registered Foreign Lawyer)

Rankings and accolades

Asian Legal Business (ALB): Thomson Reuters: Asia Dealmakers (2024)

China Business Law Journal (CBLJ) “The A-List” elite lawyers in China - Growth Driver (2023-2025)

The Legal 500 Asia Pacific - Leading Partner: Life Sciences and Healthcare in China (Foreign Firm) (2025)

Chambers and Partners Greater China - Up and Coming: Life Sciences in China (International Firm) (2025)

IFLR1000 Asia Pacific Rankings - Highly Regarded Lawyer: Capital Markets, M&A and Private Equity practices in China (Foreign Firm) (2024)

Asian Legal Business (ALB), Thomson Reuters: China Top 15 Capital Markets Lawyers (2022)

Asian Legal Business (ALB), Thomson Reuters: China Top 15 Rising Lawyers (2022)